569 related articles for article (PubMed ID: 8712720)
1. Antitumor activity of phenothiazine-related compounds.
Nagy S; Argyelan G; Molnár J; Kawase M; Motohashi N
Anticancer Res; 1996; 16(4A):1915-8. PubMed ID: 8712720
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activity of 1-[2-(chloroethyl)-3-(2-substituted-10H-phenothiazin-10-yl)alkyl- 1-urea s as potent anticancer agents.
Motohashi N; Kawase M; Kurihara T; Hevér A; Nagy S; Ocsocvszki I; Tanaka M; Molnár J
Anticancer Res; 1996; 16(5A):2525-32. PubMed ID: 8917346
[TBL] [Abstract][Full Text] [Related]
3. The in vitro antitumor assay of "half-mustard type" phenothiazines in screens of AIDS-related leukemia and lymphomas.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Molnár J
Anticancer Res; 1997; 17(5A):3425-9. PubMed ID: 9413181
[TBL] [Abstract][Full Text] [Related]
4. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulating activities on cellular cytotoxicity and the blast transformation of human lymphocytes by 10-[n-(phthalimido)alkyl-2-substituted-10H-phenothiazines and 1-(2-chloroethyl)-3-(2-substituted-10 H-phenothiazin-10-yl)alkyl-1-ureas.
Petri IB; Szekeres E; Varga E; Berek I; Molnár J; Berek L; Kawase M; Motohashi N
Anticancer Res; 1996; 16(3A):1247-50. PubMed ID: 8702245
[TBL] [Abstract][Full Text] [Related]
6. Induction of a protective immunity in mice against Escherichia coli by phenothiazines, 10-[n-(phthalimido)alkyl]-2-substituted-10H-phenothiazines and 1-(2-chloroethyl)-3-(2-substituted-10H-phenothiazines-10-yl)alkyl-1 -ureas .
Komatsu N; Motohashi N; Fujimaki M; Molnár J
In Vivo; 1997; 11(1):13-6. PubMed ID: 9067767
[TBL] [Abstract][Full Text] [Related]
7. Induction of DNA fragmentation in human myelogenous leukaemic cell lines by phenothiazine-related compounds.
Sakagami H; Takahashi H; Yoshida H; Yamamura M; Fukuchi K; Gomi K; Motohashi N; Takeda M
Anticancer Res; 1995; 15(6B):2533-40. PubMed ID: 8669819
[TBL] [Abstract][Full Text] [Related]
8. The primary in vitro antitumor screening of "half-mustard type" phenothiazines.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Nacsa J; Molnár J
Anticancer Res; 1997; 17(5A):3409-23. PubMed ID: 9413180
[TBL] [Abstract][Full Text] [Related]
9. Relationship between cytotoxic activity and dipole moment for phthalimido- and chloroethyl-phenothiazines.
Kurihara T; Motohashi N; Sakagami H; Molnár J
Anticancer Res; 1999; 19(5B):4081-3. PubMed ID: 10628357
[TBL] [Abstract][Full Text] [Related]
10. Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance.
Ford JM; Prozialeck WC; Hait WN
Mol Pharmacol; 1989 Jan; 35(1):105-15. PubMed ID: 2563302
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives.
Bisi A; Meli M; Gobbi S; Rampa A; Tolomeo M; Dusonchet L
Bioorg Med Chem; 2008 Jul; 16(13):6474-82. PubMed ID: 18522868
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of phenothiazine derivatives as potential inhibitors of phospholipase C.
Brufani M; Cesta MC; Filocamo L; Lappa S; Marta M; Pomponi M; Meroni C; Pagella PG
Farmaco; 1992 May; 47(5):585-97. PubMed ID: 1388603
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-inflammatory activity of some heterocyclic derivatives of phenothiazine.
Sharma S; Srivastava VK; Kumar A
Pharmazie; 2005 Jan; 60(1):18-22. PubMed ID: 15700774
[TBL] [Abstract][Full Text] [Related]
14. N-acylaminophenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer's disease.
González-Muñoz GC; Arce MP; López B; Pérez C; Romero A; del Barrio L; Martín-de-Saavedra MD; Egea J; León R; Villarroya M; López MG; García AG; Conde S; Rodríguez-Franco MI
Eur J Med Chem; 2011 Jun; 46(6):2224-35. PubMed ID: 21420206
[TBL] [Abstract][Full Text] [Related]
15. Drug resistance reversal, anti-mutagenicity and antiretroviral effect of phthalimido- and chloroethyl-phenothiazines.
Motohashi N; Kurihara T; Kawase M; Hevér A; Tanaka M; Szabo D; Nacsa J; Yamanaka W; Kerim A; Molnár J
Anticancer Res; 1997; 17(5A):3537-43. PubMed ID: 9413199
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo activity of 1-aryl-3-(2-chloroethyl) urea derivatives as new antineoplastic agents.
Lacroix J; Gaudreault RC; Pagé M; Joly LP
Anticancer Res; 1988; 8(4):595-8. PubMed ID: 3052247
[TBL] [Abstract][Full Text] [Related]
17. Design of new phenothiazine-thiadiazole hybrids via molecular hybridization approach for the development of potent antitubercular agents.
Ramprasad J; Nayak N; Dalimba U
Eur J Med Chem; 2015 Dec; 106():75-84. PubMed ID: 26520841
[TBL] [Abstract][Full Text] [Related]
18. Diverse biological activities displayed by phenothiazines, benzo[a]phenothiazines and benz[c]acridins (review).
Molnár J; Sakagami H; Motohashi N
Anticancer Res; 1993; 13(4):1019-25. PubMed ID: 8352520
[TBL] [Abstract][Full Text] [Related]
19. [Derivatives of 2-phenothiazin-2'-yl-cinchoninic acid with analgesic and anti-inflammatory activity].
Sparatore F; Savelli F; Cordella G
Farmaco Sci; 1980 Sep; 35(9):735-51. PubMed ID: 6969670
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of 4-amino-substituted 7-methoxy (and 7-hydroxy)- 11-methyl (and 5,11-dimethyl)-10H-pyrido [2,3-b] carbazoles and 4-amino- substituted 11-methyl (and 5,11-dimethyl)-10H-pyrido[3',4':4,5] pyrrolo [3,2-g] quinolines, two new series related to antitumor ellipticine derivatives.
Moron J; Rautureau M; Huel C; Pierré A; Berthier LK; Atassi G; Bisagni E
Anticancer Drug Des; 1993 Dec; 8(6):399-416. PubMed ID: 8286009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
